Injections, implants tested as new weapons to prevent HIV

Romanian prostitutes pose in the brothel "Pussy Club" in SchoenefeldBy Ben Hirschler LONDON (Reuters) – Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months. Companies with drugs involved include GlaxoSmithKline, Gilead Sciences and Merck. The initiatives build on the success of Gilead's once-daily pill Truvada, which has proved remarkably effective at stopping HIV infection during sex.

Sexual Health News Headlines – Yahoo! News